NAV
$73.44
AUM
$1.8B
Expense Ratio
-
Dividend Yield
1.66%
Beta
0.88
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.67% | +3.20% | +7.07% | +17.20% | +16.63% | +9.66% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 4.50% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.31% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.12% |
| 4 | AZN.L | AstraZeneca PLC | 2.07% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 2.06% |
| 6 | NESN.SW | Nestle SA | 1.88% |
| 7 | SHEL.L | Shell PLC | 1.71% |
| 8 | SIE.DE | Siemens AG | 1.66% |
| 9 | SAP.DE | SAP SE | 1.33% |
| 10 | SAN.MC | Banco Santander SA | 1.32% |
The index measures the performance of the securities of leading companies in the following countries: Austria, Belgium, Denmark, Finland, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden and Switzerland). The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index.
Inception Date: 2000-07-25